Eugenio Jiménez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eugenio Jiménez has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Mercedes Montiel
Department of Biochemistry and Molecular Biology, Malaga University, Malaga, Spain
3 shared publications Mercedes Montiel
Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad de Málaga, Campus de Teatinos s/n, 29071 Málaga, Spain
2 shared publicationsElisa Martı́n
1 shared publicationJosé Pavı́a
1 shared publicationJuan Quesada
Departamento de Bioquı́mica y Biologı́a Molecular, Facultad de Medicina, Universidad de Málaga, Campus de Teatinos s/n, 29071 Málaga, Spain
1 shared publicationM.Idoia Gámez
Departamento de Bioquı́mica y Biologı́a Molecular, Facultad de Medicina, Universidad de Málaga, Campus de Teatinos s/n, 29080 Málaga, Spain
1 shared publication
Latest Publications
- 2 March 2005
- Published by Wiley in Journal of Cellular Physiology
- Vol. 204 (2) , 678-686
Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells
Carbachol (Cch), a muscarinic acetylcholine receptor (mAChR) agonist, increases intracellular‐free Ca2+ mobilization and induces mitogen‐activated protein kinase/extracellular signal‐regulated kinase (MAPK/ERK) phosphorylation in MCF‐7 human breast cancer cells. Pretreatment of cells with the selective phospholipase C (PLC) inhibitor U73122, or incubation of cells in a Ca2+‐free medium did not alter Cch‐stimulated MAPK/ERK phosphorylation. Phosphorylation of MAPK/ERK was mimicked by phorbol 12‐myristate acetate (PMA), an activator of protein kinase C (PKC), but Cch‐evoked MAPK/ERK activation was unaffected by down‐regulation of PKC or by pretreatment of cells with GF109203X, a PKC inhibitor. However, Cch‐stimulated MAPK/ERK phosphorylation was completely blocked by myristoylated PKC‐ζ pseudosubstrate, a specific inhibitor of PKC‐ζ, and high doses of staurosporine. Pretreatment of human breast cancer cells with wortmannin or LY294002, selective inhibitors of phosphoinositide 3‐kinase (PI3K), diminished Cch‐mediated MAPK/ERK phosphorylation. Similar results were observed when MCF‐7 cells were pretreated with genistein, a non‐selective inhibitor of tyrosine kinases, or with the specific Src tyrosine kinase inhibitor PP2. Moreover, in MCF‐7 human breast cancer cells mAChR stimulation induced an increase of protein synthesis and cell proliferation, and these effects were prevented by PD098059, a specific inhibitor of the mitogen activated kinase kinase. In conclusion, analyses of mAChR downstream effectors reveal that PKC‐ζ, PI3K, and Src family of tyrosine kinases, but not intracellular‐free Ca2+ mobilization or conventional and novel PKC activation, are key molecules in the signal cascade leading to MAPK/ERK activation. In addition, MAPK/ERK are involved in the regulation of growth and proliferation of MCF‐7 human breast cancer cells.
- 2 March 2005
- Published by Wiley in Journal of Cellular Physiology
- Vol. 204 (2) , 678-686
Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells
Carbachol (Cch), a muscarinic acetylcholine receptor (mAChR) agonist, increases intracellular‐free Ca2+ mobilization and induces mitogen‐activated protein kinase/extracellular signal‐regulated kinase (MAPK/ERK) phosphorylation in MCF‐7 human breast cancer cells. Pretreatment of cells with the selective phospholipase C (PLC) inhibitor U73122, or incubation of cells in a Ca2+‐free medium did not alter Cch‐stimulated MAPK/ERK phosphorylation. Phosphorylation of MAPK/ERK was mimicked by phorbol 12‐myristate acetate (PMA), an activator of protein kinase C (PKC), but Cch‐evoked MAPK/ERK activation was unaffected by down‐regulation of PKC or by pretreatment of cells with GF109203X, a PKC inhibitor. However, Cch‐stimulated MAPK/ERK phosphorylation was completely blocked by myristoylated PKC‐ζ pseudosubstrate, a specific inhibitor of PKC‐ζ, and high doses of staurosporine. Pretreatment of human breast cancer cells with wortmannin or LY294002, selective inhibitors of phosphoinositide 3‐kinase (PI3K), diminished Cch‐mediated MAPK/ERK phosphorylation. Similar results were observed when MCF‐7 cells were pretreated with genistein, a non‐selective inhibitor of tyrosine kinases, or with the specific Src tyrosine kinase inhibitor PP2. Moreover, in MCF‐7 human breast cancer cells mAChR stimulation induced an increase of protein synthesis and cell proliferation, and these effects were prevented by PD098059, a specific inhibitor of the mitogen activated kinase kinase. In conclusion, analyses of mAChR downstream effectors reveal that PKC‐ζ, PI3K, and Src family of tyrosine kinases, but not intracellular‐free Ca2+ mobilization or conventional and novel PKC activation, are key molecules in the signal cascade leading to MAPK/ERK activation. In addition, MAPK/ERK are involved in the regulation of growth and proliferation of MCF‐7 human breast cancer cells.
- 31 August 2004
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 223 (1-2) , 35-41
Activation of second messenger-dependent protein kinases induces muscarinic acetylcholine receptor desensitization in rat thyroid epithelial cells
- 31 August 2004
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 223 (1-2) , 35-41
Activation of second messenger-dependent protein kinases induces muscarinic acetylcholine receptor desensitization in rat thyroid epithelial cells
- 14 May 2002
- Published by Elsevier in Cellular Signalling
- Vol. 14 (8) , 665-672
Muscarinic activation of mitogen-activated protein kinase in rat thyroid epithelial cells
- 14 May 2002
- Published by Elsevier in Cellular Signalling
- Vol. 14 (8) , 665-672
Muscarinic activation of mitogen-activated protein kinase in rat thyroid epithelial cells
- 1 February 2001
- Published by Elsevier in Biochemical Pharmacology
- Vol. 61 (3) , 337-342
Muscarinic receptor subtypes and calcium signaling in Fischer rat thyroid cells
- 1 February 2001
- Published by Elsevier in Biochemical Pharmacology
- Vol. 61 (3) , 337-342
Muscarinic receptor subtypes and calcium signaling in Fischer rat thyroid cells
- 12 April 1999
- Published by Elsevier in Biochemical Pharmacology
- Vol. 57 (10) , 1125-1131
Angiotensin II receptor internalization and signaling in isolated rat hepatocytes
- 12 April 1999
- Published by Elsevier in Biochemical Pharmacology
- Vol. 57 (10) , 1125-1131
Angiotensin II receptor internalization and signaling in isolated rat hepatocytes